Guidelines:Endometrial cancer/Treatment/Early stage/Conflict of interest
Guideline contents > Conflict of interest
Guidelines commissioned by |
Conflict of interest summary
Working party members
| Author | Conflict of interest declaration |
|---|---|
| Dr Alison Brand (Chair)
Gynaecological Oncologist – Westmead Hospital, Sydney NSW |
No conflict of interest to declare |
| Professor Ian Hammond (Deputy Chair)
Gynaecological Oncologist, Cancer Australia Advisory Group/ King Edward Memorial Hospital, Perth WA |
No conflict of interest to declare |
| Dr Robyn Cheuk
Radiation Oncologist, Cancer Australia Advisory Group/ Royal Brisbane and Womens Hospital, Brisbane QLD |
No conflict of interest to declare |
| Kathryn Crisell
Gynaecological cancer consumer, Adelaide SA |
No conflict of interest to declare |
| Assoc Professor Margaret Davy
Gynaecological Oncologist, Cancer Australia Advisory Group/ Royal Adelaide Hospital, Adelaide SA |
Has been a member of the GSK Advisory Board for Cervarix and also given lectures sponsored by GSK and CSL |
| Dr Andrew Dean
Medical Oncologist, St John of God Hospital, Perth WA |
Has been on an Advisory Board for Specialised Therapeutics Australia and received an honorarium from them |
| Dr Louise Farrell
Gynaecologist, King Edward Memorial Hospital, Perth WA |
Has received sponsorship to attend meetings from GSK, MSD and CSL. Has received a grant from GSK to run a survey of Gynaecologists’ attitude to HPV vaccines. Is an investigator in both CSL and GSK HPV vaccine trials |
| Jane Francis
Manager, Gynaecological Cancers, Cancer Australia |
No conflict of interest to declare |
| Clinical Associate Professor Russell Hogg
Gynaecological Oncologist, Westmead Hospital, Sydney NSW |
No conflict of interest to declare |
| Lesley McQuire
Gynaecological cancer consumer, Sydney NSW |
No conflict of interest to declare |
| Dr Selvan Pather
Gynaecological Oncologist, Royal Prince Alfred Hospital, Sydney NSW |
No conflict of interest to declare |
| Dr Frances Quirk
Sexologist, Townsville QLD |
No conflict of interest to declare |
| Dr Felicity Rea
General Practitioner, Toowoomba QLD |
No conflict of interest to declare |
| Dr Colin Stewart
Histopathologist, WA |
No conflict of interest to declare |
| Ella Curnow
Project Officer - Cancer Australia |
No conflict of interest to declare |
| Professor Ian Olver AM (Convenor)
CEO - Cancer Council Australia |
No conflict of interest to declare |
| Christine Vuletich
Manager - Clinical Guidelines Network, Cancer Council Australia |
No conflict of interest to declare |
| Alice Winter-Irving
Project Officer - Clinical Guidelines Network, Cancer Council Australia |
No conflict of interest to declare |
| Jutta von Dincklage
Project Manager - Wiki Development, Cancer Council Australia |
No conflict of interest to declare |
Contributing authors
| Author | Conflict of interest declaration |
|---|---|
| Dr Linda Mileshkin
Medical Oncologist, Peter MacCallum Cancer Centre Melbourne VIC |
Australian PI for ANZGOG international PORTEC 3 trial. Hospira is supplying paclitaxel for Australian patients in this trial. |
| Dr Marcelo C Nascimento
Gynaecological Oncologist, Mater Hospital and Gold Coast Hospital, QLD |
No conflict of interest to declare |
| Professor Andreas ObermairGynaecological Oncologist, Queensland Centre for Gynaecological Cancer, The University of Queensland, Brisbane QLD | Has received sponsorship to attend conferences from Gate Health who market the McCartney tube |
| Dr Kym Reid
Gynaecological Oncology Fellow, Brisbane QLD |
No conflict of interest to declare |
| Dr Colin Stewart
Histopathologist, St John of God Pathology, Perth WA |
No conflict of interest to declare |
| Ai Ling Tan
Gynaecological Oncologist Auckland, New Zealand |
Involved in a trial as an investigator sponsored by GSK
Prevalance of HPV16,18 in cervical cancer in NZ women |
